Document:

exv10w1

 

Exhibit 10.1

TERMINATION OF CONSULTING AGREEMENT

     This Termination of Consulting Agreement (this “Agreement”) is made as of December 15, 2004 by
and between PeopleSoft, Inc. (the “Company”) and Aneel Bhusri (“Consultant”).

RECITALS

     WHEREAS, the Company and Consultant previously have entered into that certain Consulting
Agreement dated as of December 6, 2004 (the “Consulting Agreement”); and

     WHEREAS, PeopleSoft and Consultant desire to terminate the Consulting Agreement.

AGREEMENT

     NOW, THEREFORE, in consideration of the covenants set forth herein and for good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and
Consultant agree as follows:

     1. Termination.

     The Consulting Agreement shall be terminated as of December 31, 2004 (the “Termination Date”)
and, following such date shall be of no further force or effect. The Company and Consultant hereby
waive the requirement of 30-days’ notice of termination in the Consulting Agreement.

     2. Pre-Termination Payments and Other Obligations.

     The obligations of the Company and Consultant under the Consulting Agreement, including the
Company’s obligation to pay Consultant the amounts owed under the Consulting Agreement, shall
continue in effect until the Termination Date.

     3. Rights and Obligations.

     Following the Termination Date, PeopleSoft and Consultant shall have no further rights or
obligations under or pursuant to the Consulting Agreement.

     4. Counterparts; Facsimile Transmission.

     This Agreement may be executed in separate counterparts, both of which are deemed to be an
original and all of which taken together shall constitute one and the same agreement. Delivery of
executed signature pages hereof by facsimile transmission shall constitute effective and binding
execution and delivery of this Agreement.

 

 

     IN WITNESS WHEREOF, each of the parties to this Agreement has caused this Agreement to be duly
executed on its behalf, as of the day and year first above written.

	 	 	 	 	 
	 	PEOPLESOFT, INC.

 	 
	 	By:  	/s/ James P. Shaughnessy
 	 
	 	 	Name:  	James P. Shaughnessy 	 
	 	 	Its: Senior Vice President and General
Counsel 	 
	 

	 	 	 	 	 
	 	ANEEL BHUSRI

 	 
	 	/s/ Aneel BhusriEx-10.1 Form of Nonstatutory Stock Option Agrmnt

 

Exhibit 10.1

ALNYLAM PHARMACEUTICALS, INC.

Nonstatutory Stock Option Agreement

Granted Under 2004 Stock Incentive Plan

1. Grant of Option.

     This agreement evidences the grant by Alnylam Pharmaceuticals, Inc., a Delaware corporation
(the “Company”),
on          ,
20[   ] (the “Grant Date”) to
[             ],
an [employee], [consultant], [director] of the Company (the “Participant”), of an option to
purchase, in whole or in part, on the terms provided herein and in the Company’s 2004 Stock
Incentive Plan (the “Plan”), a total of [             ] shares (the “Shares”) of
common stock, $.01 par value per share, of the Company (“Common Stock”) at $[             ]
per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [the
date that is ten years from the Grant
Date]       (the “Final Exercise Date”).

     It is intended that the option evidenced by this agreement shall not be an incentive stock
option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any
regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the
term “Participant”, as used in this option, shall be deemed to include any person who acquires the
right to exercise this option validly under its terms.

2. Vesting Schedule.

     This
option will become exercisable (“vest”) as to
[             ].

     The right of exercise shall be cumulative so that to the extent the option is not exercised in
any period to the maximum extent permissible it shall continue to be exercisable, in whole or in
part, with respect to all Shares for which it is vested until the earlier of the Final Exercise
Date or the termination of this option under Section 3 hereof or the Plan.

3. Exercise of Option.

     (a) Form of Exercise. Each election to exercise this option shall be in writing,
signed by the Participant, and received by the Company at its principal office, accompanied by this
agreement, and payment in full in the manner provided in the Plan. The Participant may purchase
less than the number of shares covered hereby, provided that no partial exercise of this option may
be for any fractional share or for fewer than ten whole shares.

(b) Continuous Relationship with the Company Required. Except as otherwise provided
in this Section 3, this option may not be exercised unless the Participant, at the time he or she
exercises this option, is, and has been at all times since the Grant Date, an [employee or officer
of], or consultant or advisor to, the Company or any other entity the employees, officers,
directors, consultants, or advisors of which are eligible to receive option grants under the Plan
(an “Eligible Participant”).

 

 

     (c) Termination of Relationship with the Company. If the Participant ceases to be an
Eligible Participant for any reason, then, except as provided in paragraphs (d) and (e) below, the
right to exercise this option shall terminate three months after such cessation (but in no event
after the Final Exercise Date), provided that this option shall be exercisable only
to the extent that the Participant was entitled to exercise this option on the date of such
cessation. Notwithstanding the foregoing, if the Participant, prior to the Final Exercise Date,
violates the non-competition or confidentiality provisions of any employment contract,
confidentiality and nondisclosure agreement or other agreement between the Participant and the
Company, the right to exercise this option shall terminate immediately upon such violation.

     (d) Exercise Period Upon Death or Disability. If the Participant dies or becomes
disabled (within the meaning of Section 22(e)(3) of the Code) prior to the Final Exercise Date
while he or she is an Eligible Participant and the Company has not terminated such relationship for
“cause” as specified in paragraph (e) below, this option shall be exercisable, within the period of
one year following the date of death or disability of the Participant, by the Participant (or in
the case of death by an authorized transferee), provided that this option shall be
exercisable only to the extent that this option was exercisable by the Participant on the date of
his or her death or disability, and further provided that this option shall not be exercisable
after the Final Exercise Date.

     (e) Discharge for Cause. If the Participant, prior to the Final Exercise Date, is
discharged by the Company for “cause” (as defined below), the right to exercise this option shall
terminate immediately upon the effective date of such discharge. “Cause” shall mean willful
misconduct by the Participant or willful failure by the Participant to perform his or her
responsibilities to the Company (including, without limitation, breach by the Participant of any
provision of any employment, consulting, advisory, nondisclosure, non-competition or other similar
agreement between the Participant and the Company), as determined by the Company, which
determination shall be conclusive. The Participant shall be considered to have been discharged for
“Cause” if the Company determines, within 30 days after the Participant’s resignation, that
discharge for cause was warranted.

4. Withholding.

     No Shares will be issued pursuant to the exercise of this option unless and until the
Participant pays to the Company, or makes provision satisfactory to the Company for payment of, any
federal, state or local withholding taxes required by law to be withheld in respect of this option.

5. Nontransferability of Option.

     This option may not be sold, assigned, transferred, pledged or otherwise encumbered by the
Participant, either voluntarily or by operation of law, except by will or the laws of descent and
distribution, and, during the lifetime of the Participant, this option shall be exercisable only by
the Participant.

6. Provisions of the Plan.

-2-

 

     This option is subject to the provisions of the Plan, a copy of which is furnished to the
Participant with this option.

     IN WITNESS WHEREOF, the Company has caused this option to be executed under its corporate seal
by its duly authorized officer. This option shall take effect as a sealed instrument.

	 	 	 	 	 
	 	ALNYLAM PHARMACEUTICALS, INC.

 	 
	Dated: 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 

-3-

 

	 	 	 	 	 

PARTICIPANT’S ACCEPTANCE

     The undersigned hereby accepts the foregoing option and agrees to the terms and conditions
thereof. The undersigned hereby acknowledges receipt of a copy of the Company’s 2004 Stock
Incentive Plan.

PARTICIPANT:

Address:

-4-EX-10.1 Voting Agreement dated December 22, 2004

 

Exhibit 10.1

VOTING AGREEMENT

     VOTING AGREEMENT (“Agreement”), dated as of December 22, 2004, by and
between Segue Software, Inc., a Delaware corporation (“Company”), and the
undersigned (each, a “Stockholder”) beneficial holders of shares of Common
Stock, Series B Preferred Stock and Series C Preferred Stock, each having par
value $0.01 per share, of the Company (the “Common Stock,” “Series B Preferred
Stock” and “Series C Preferred Stock, respectively).

     WHEREAS, the shares of Common Stock, Series B Preferred Stock and Series C
Preferred Stock beneficially held by the Stockholders, together with any shares
of capital stock of the Company hereafter issued as a dividend in respect
thereof, are collectively referred to herein as the “Shares”.

     WHEREAS, the Board of Directors of the Company (“Board”) has adopted
resolutions approving an Amendment to the Restated Certificate of Incorporation
of the Company providing for a change in the dividend and redemption rights of
the Series B Preferred Stock (“Amendment”), as contained within Exhibit A of
the Certificate of Designations, Preferences and Rights of a Series of
Preferred Stock of Segue Software, Inc.;

     WHEREAS, the Stockholders beneficially own and have voting power with
respect to the Shares;

     WHEREAS, the Company agrees, subject to the Board’s exercise of its
fiduciary duties, to submit the Amendment to a vote of the Company’s
stockholders at the Company’s next annual meeting;

     WHEREAS, it is a requirement for the adoption of the Amendment that the
Stockholders vote, or cause the vote of, the Shares in support of the
Amendment.

     NOW, THEREFORE, in consideration of the Company adopting the Amendment and
the expenses incurred and to be incurred by the Company in connection
therewith, the Stockholders and the Company agree as follows:

     1. Agreement to Vote Shares. Each of the Stockholders agrees that, at any
meeting of the stockholders of the Company, or in connection with a written
consent by such Stockholder, such Stockholder shall vote (or cause to be
voted), or deliver a written consent (or cause a consent to be delivered)
covering all of the Shares that such Stockholder shall be entitled to so vote,
whether such Shares are beneficially owned by such Stockholder on the date of
this Agreement or are subsequently acquired, in favor of adoption and approval
of the Amendment.

     2. Agreement to Retain Shares. From and after the date hereof until June
30, 2005, neither of the Stockholders shall, except as contemplated by this
Agreement, directly or indirectly, sell, assign, transfer, assign, or otherwise
dispose of (including, without limitation, by the creation of a lien, claim or
other encumbrance), or enter into any contract, option, commitment or other
arrangement or understanding with respect to the sale, transfer, assignment

 

 

or other disposition of, any Shares owned by the Stockholders, whether
such Shares are held by the Stockholders on the date of this Agreement or are
subsequently acquired. Notwithstanding the foregoing, the Stockholders may
make (a) transfers by will, or by operation of law, in which case this
Agreement shall bind the transferee, (b) transfers in connection with estate
and charitable planning purposes, including transfers to relatives, trusts and
charitable organizations, subject to the transferee agreeing in writing to be
bound by the terms of, and perform the obligations of the Stockholders under,
this Agreement, and (c) transfers as the Company may otherwise agree in writing
in its sole discretion.

     3. Representations and Warranties of the Stockholders. Each of the
Stockholders, jointly and severally, hereby represents and warrants to the
Company as follows:

	(a)	 	such Stockholder has the complete and
unrestricted power and the unqualified right to enter into and
perform the terms of this Agreement;
	 
	(b)	 	this Agreement (assuming this Agreement
constitutes a valid and binding agreement of the Company) is a
valid and legally binding agreement with respect to such
Stockholder, enforceable in accordance with its terms;
	 
	(c)	 	as of the date hereof, the Stockholders
beneficially owns the number of Shares indicated on Schedule 1
attached hereto, free and clear of any liens, claims, charges
or other encumbrances or restrictions of any kind whatsoever,
and have sole and otherwise unrestricted, voting power with
respect to such Shares;
	 
	(d)	 	the execution and delivery of this Agreement by
such Stockholder does not, and the performance by such
Stockholder of his, her or its obligations hereunder and the
consummation by such Stockholder of the transactions
contemplated hereby will not, violate or conflict with, or
constitute a default under, any agreement, instrument,
contract or other obligation or any order, arbitration award,
judgment or decree to which such Stockholder is a party or by
which such Stockholder is bound, or any statute, rule or
regulation to which such Stockholder is subject.

     4. Irrevocable Proxy. Subject to the last sentence of this Section 4, by
execution of this Agreement, each Stockholder does hereby appoint Company with
full power of substitution and resubstitution, as such Stockholder’s true and
lawful attorney and irrevocable proxy, to the full extent of such Stockholder’s
rights with respect to the Shares, to vote, if such Stockholder is unable or
unwilling to perform his, her or its obligations under this Agreement, each of
such Shares solely with respect to the matters set forth in Section 1 hereof.
Each Stockholder intends the proxy granted by this Section 4 to be irrevocable
and coupled with an interest hereafter until June 30, 2005, and hereby revokes
any proxy previously granted by such Stockholder with respect to the Shares.
Notwithstanding anything contained herein to the contrary, this irrevocable
proxy shall automatically terminate on June 30, 2005.

     5. Specific Enforcement. The Stockholders have signed this Agreement
intending to be legally bound thereby. The Stockholders expressly agree that
this Agreement shall be

2

 

specifically enforceable in any court of competent jurisdiction in
accordance with its terms against the Stockholders. All of the covenants and
agreements contained in this Agreement shall be binding upon, and inure to the
benefit of, the respective parties and their permitted successors, assigns,
heirs, executors, administrators and other legal representatives, as the case
may be.

     6. Counterparts. This Agreement may be executed in one or more
counterparts, each of which will be deemed an original but all of which
together shall constitute one and the same instrument.

     7. No waivers. No waiver of any provisions hereof by either party shall
be deemed a waiver of any other provisions hereof by any such party, nor shall
any such waiver be deemed a continuing waiver of any provision hereof by such
party.

     8. Miscellaneous. This Agreement is to be governed by the laws of the
State of Delaware, without giving effect to the principles of conflicts of laws
thereof. If any provision hereof is deemed unenforceable, the enforceability
of the other provisions hereof shall not be affected.

     9. Capacity as Stockholders. The Stockholders sign this Agreement solely
in their capacity as a stockholder of the Company or beneficial owner of
Shares, and not in such Stockholder’s capacity as a director, officer or
employee of the Company or any of its subsidiaries (as applicable).

     10. Entire Agreement. This Agreement supersedes all prior agreements,
written or oral, among the parties hereto with respect to the subject matter
hereof and contains the entire agreement among the parties with respect to the
subject matter hereof. This Agreement may not be amended, supplemented or
modified, and no provisions hereof may be modified or waived, except by an
instrument in writing signed by each party hereto.

[SIGNATURE PAGE FOLLOWS]

3

 

     IN WITNESS WHEREOF, this Voting Agreement is executed into as of the date
first above written.

	 	 	 	 	 	 	 
	 	 	STOCKHOLDER
	 
	 	 	 	 	 	 
	 	 	S-7 ASSOCIATES, LLC
	 
	 	 	 	 	 	 
	

	 	By:	 	 /s/ James Simons	 	 
	

	 	 	 	
	 	 
	

	 	Name:	 	 James Simons	 	 
	

	 	Title:	 	 Managing Director	 	 
	 
	 	 /s/ James Simons	 	 	 	 
	 	 	

	 	 	James Simons
	 
	 	 	 	 	 	 
	 	 	SEGUE SOFTWARE, INC.
	 
	 	 	 	 	 	 
	

	 	By:	 	 /s/ Douglas Zaccaro	 	 
	

	 	 	 	
	 	 
	

	 	Name:	 	 Douglas Zaccaro	 	 
	

	 	 	 	
	 	 
	

	 	Title:	 	 Chief Financial Officer	 	 
	

	 	 	 	
	 	 

 

 

SCHEDULE 1        

	 	 	 
	Stockholder	 	Shares
	 
	S-7 Associates, LLC	 	48,100 Common Stock
868,838
Series B Preferred Stock
171,720 Series C Preferred Stock
	 
	James Simons	 	286,666 Common Stock

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00076-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00076-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00076-of-00352.parquet"}]]